Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Immune Reconstitution”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Testing effectiveness (Phase 2)UnknownNCT02648516
What this trial is testing

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency VirusDisorder of Immune Reconstitution
Beijing 302 Hospital 20
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Testing effectiveness (Phase 2)WithdrawnNCT01882387
What this trial is testing

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Very early researchStudy completedNCT04963712
What this trial is testing

Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder

Who this might be right for
HIV-1-infection
Shanghai Public Health Clinical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT01712945
What this trial is testing

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 40
Not applicableStudy completedNCT04756687
What this trial is testing

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 1,507
Not applicableStudy completedNCT02395289
What this trial is testing

Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)

Who this might be right for
Human Immunodeficiency Virus
Emory University 54
Not applicableLooking for participantsNCT06441669
What this trial is testing

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Who this might be right for
Cytomegalovirus Infection Reactivation
Anhui Provincial Hospital 60
Large-scale testing (Phase 3)Study completedNCT02476617
What this trial is testing

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 25
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT00000905
What this trial is testing

Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT01490346
What this trial is testing

Tissue Drug Levels of HIV Medications

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 22
Not applicableLooking for participantsNCT05425043
What this trial is testing

Granulocyte Transfusions After Umbilical Cord Blood Transplant

Who this might be right for
Pediatric Cancer
University of Manchester 40
Testing effectiveness (Phase 2)Study completedNCT00993486
What this trial is testing

Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Hematologic DiseasesHematologic Malignancies
Kiadis Pharma 19
Not applicableStudy completedNCT00001078
What this trial is testing

A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableLooking for participantsNCT06854094
What this trial is testing

Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Ente Ospedaliero Cantonale, Bellinzona 70
Testing effectiveness (Phase 2)Looking for participantsNCT04959903
What this trial is testing

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Who this might be right for
Hematological Malignancies
Smart Immune SAS 36
Not applicableStudy completedNCT02063880
What this trial is testing

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Who this might be right for
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
University of Washington 183
Load More Results